NDE1 and psychiatric disorder: This study has, therefore, provided new biological insight into psychiatric disorders for which novel medications could be designed, as well as suggesting that knowledge of an individual's genotype within the NDE1/miR-484 locus may have potential value in the targeting of current therapies.